Loading clinical trials...
Loading clinical trials...
Patients who are severely ill with COVID-19 may benefit from receiving plasma infusions from donors who have recovered from the disease and are proven to no longer be infected. Efforts to initiate the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Thomas Jefferson University
NCT01306084 · Anogenital Herpes, COVID-19, and more
NCT04551378 · COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, and more
NCT05218083 · COVID-19, Critical Illness, and more
NCT05078905 · COVID-19, Vaccination, and more
NCT07552779 · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), and more
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions